Efficacy and safety of Nilutamide in patients with metastatic prostate cancer who underwent orchiectomy: A systematic review and meta-analysis.

CONCLUSION: Evidence suggests that patients with mPCa who underwent orchiectomy receiving Nilutamide showed significant improvement in progression-free survival and overall survival response rate and clinical benefits in comparison with the placebo group. PMID: 30648519 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30648519?dopt=Abstract

Source: Current Clinical Pharmacology - January 12, 2019 Category: Drugs & Pharmacology Authors: Rashid M, Shamshavali K, Chhabra M Tags: Curr Clin Pharmacol Source Type: research